New York based global biopharmaceutical company Bristol Meyers Squibb will invest $100 million to establish a facility in Hyderabad, India, to expand its global drug development and IT capabilities. The firm plans to begin its operations in Hyderabad in the second half of 2023 and employ approximately 1,500 people. According to...